Have an account?
Log in to check out faster.
Welcome to the latest edition of the M2MMA Combat Sports Blog, where we delve into the most significant events from this past weekend.
On Saturday, February 1, 2025, the anb Arena in Riyadh, Saudi Arabia, hosted UFC Fight Night 250, headlined by a pivotal middleweight clash between former champion Israel Adesanya and rising contender Nassourdine Imavov. In a surprising turn, Imavov secured the biggest win of his career, delivering a second-round TKO against Adesanya. This victory propels Imavov into the title picture, while Adesanya faces an uncertain path forward.
On February 1, 2025, Oktagon 66 took place at the PSD Bank Dome in Düsseldorf, Germany. The event featured the opening round of the Tipsport Gamechanger Middleweight Tournament, with several notable bouts.
On February 1, 2025, at the T-Mobile Arena in Las Vegas, David Benavidez faced David Morrell in a high-stakes light heavyweight bout. The fight was a thrilling contest, with both fighters showcasing their skills and resilience. Benavidez emerged victorious via unanimous decision, with judges scoring the bout 115-111, 115-111, and 118-108 in his favor. This win solidifies Benavidez's position as a leading contender in the light heavyweight division and sets the stage for a potential undisputed title shot against the winner of the upcoming rematch between Artur Beterbiev and Dmitry Bivol.
M2MMA is a revolutionary combat sports promotion that transforms the industry through cutting-edge innovation, advanced technology, and a steadfast commitment to athlete welfare. By integrating artificial intelligence, data-driven insights, and forward-thinking strategies, M2MMA enhances athlete safety, optimizes performance, and redefines the fan experience. Focusing on community engagement and fostering a dynamic future for combat sports, M2MMA stands at the intersection of technology and tradition, driving progress while honoring the sport's rich heritage.
The company is publicly traded on the Over-the-Counter Bulletin Board (OTCBB) of NASDAQ under the ticker symbol "RLAB."
RLAB/M2MMA is majority controlled by M2Bio Sciences, which is also publicly traded on the Over-the-Counter market under the ticker symbol (OTC Pink: MRES)
MANAGING DIRECTOR OF M2MMA